Daily Current Affairs And General Studies For UPSC Prelims And Mains (July 2): Police Reforms; Industrial Accidents And Safety Protocol; Vaccine And Safety Aspects

Police Reform:  Lesson from Thoothukudi

This fatal violence by state actors is a cruel reminder of just how little unshackling has happened in the domain of policing.

The Madras High Court acted in the best traditions of constitutional courts in India, which have often passed various directions to try and ameliorate the problem of police violence.

In the case, Prakash Singh v. Union of India [(2006) 8 SCC 1], the Supreme Court pushed through new legislation for governing police forces to be passed by States across India.

A key component of the new legislation was a robust setup for accountability that contemplated a grievance redress mechanism. That it took reportedly 11 years for the State of Tamil Nadu to actually implement Prakash Singh (a law passed in 2013 but only given effect in 2017), and that several States remain in contempt of the Supreme Court’s judgment, give some insights into how seriously the issue of police reform ranks in the scheme of things for governments.

Source: The Hindu (Police reform and the crucial judicial actor)

Industrial Accidents And Safety Protocol

Two deadly industrial disasters, in Tamil Nadu and Andhra Pradesh, leading to the loss of at least eight lives and causing serious injuries to many, once again underscore the value of safety protocols.

The response of the Centre and States to industrial accidents is usually to stem public outrage by announcing compensation for victims. A transparent inquiry that leads to a fixing of responsibility and reform is a low priority. This culture must change. Such accidents are mostly preventable, and occur rarely in the industrialised world, because of impeccable attention to safety. India’s aspirations to industrialise should be founded on safety.

Source: the Hindu Edit (Lax on safety)

India’s first indigenous COVID-19 vaccine (COVAXIN) And Safety Aspects

India’s first indigenous COVID-19 vaccine (COVAXIN) developed by a Hyderabad-based company in collaboration with the ICMR is all set to be tested on humans. The permission from the Drugs Controller General of India to carry out phase-1 and phase-2 human clinical trials was based on the safety and efficacy results of studies on mice, rats and rabbits.

If scientists develop a safe, efficacious vaccine soon, public trust in science could grow substantially but there would be serious consequences if it fails, particularly on the safety aspect. Regulatory agencies have a responsibility to ensure COVID-19 vaccines deliver what they promise.

Source: The Hindu Edit (Promise and delivery)

 154 total views,  2 views today